Moderate to Severe Psoriasis (4^th Ed.)

Written by experts in the dermatology field, this new fourth edition of Moderate-to-Severe Psoriasis discusses the current use of biologics and other pharmacologic and phototherapy treatments for moderate-to-severe psoriasis. Illustrated with high quality color figures, this standalone text emphasizes safe and effective treatments for the psoriasis patient that are perfect for the dermatologist in daily practice. New to this edition are chapters on day treatment programs, new agents, erythrodermic and pustular psoriasis, special populations, and pharmacogenetics.

An Overview of Psoriasis. Evaluating Psoriasis in Patients. Topical Agents in the Treatment of Moderate to Severe Psoriasis. The Art and Practice of UVB Phototherapy and Laser for the Treatment of Moderate-to-Severe PSO. Systemic and Topical PUVA Therapy. Therapy of Moderate-To-Severe PSO with MTX. Systemic Retinoids. Cyclosporine in the treatment of severe PSO. Combination, Rotational, and Sequential Therapies. Pediatric Psoriasis, Maya Debbaneh. Psoriatic Arthritis. Etanercept for Treatment of Psoriasis. Adalimumab in the Treatment of Psoriasis. Infliximab in the treatment of PSO. New Agents: IL-17, JAK Kinase. Ustekinumab. Current and Potential Applications of Pharmacogenetics and Pharmacogenomics in the Treatment of PSO. The Immunomodulatory/Immunosuppressive Classification System. Goeckerman and Ingram Day Treatment Program.